145 related articles for article (PubMed ID: 37638972)
1. [Achromatopsia : Clinical aspects, diagnostics, genes, brain and quality of life].
Käsmann-Kellner B; Hoffmann MB
Ophthalmologie; 2023 Sep; 120(9):975-986. PubMed ID: 37638972
[TBL] [Abstract][Full Text] [Related]
2. Novel mutations in the gene for α-subunit of retinal cone cyclic nucleotide-gated channels in a Japanese patient with congenital achromatopsia.
Kuniyoshi K; Muraki-Oda S; Ueyama H; Toyoda F; Sakuramoto H; Ogita H; Irifune M; Yamamoto S; Nakao A; Tsunoda K; Iwata T; Ohji M; Shimomura Y
Jpn J Ophthalmol; 2016 May; 60(3):187-97. PubMed ID: 27040408
[TBL] [Abstract][Full Text] [Related]
3. Retinal morphology of patients with achromatopsia during early childhood: implications for gene therapy.
Yang P; Michaels KV; Courtney RJ; Wen Y; Greninger DA; Reznick L; Karr DJ; Wilson LB; Weleber RG; Pennesi ME
JAMA Ophthalmol; 2014 Jul; 132(7):823-31. PubMed ID: 24676353
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of the achromatopsia genes CNGA3 and CNGB3 in progressive cone dystrophy.
Thiadens AA; Roosing S; Collin RW; van Moll-Ramirez N; van Lith-Verhoeven JJ; van Schooneveld MJ; den Hollander AI; van den Born LI; Hoyng CB; Cremers FP; Klaver CC
Ophthalmology; 2010 Apr; 117(4):825-30.e1. PubMed ID: 20079539
[TBL] [Abstract][Full Text] [Related]
5. A deep intronic substitution in
Aweidah H; Salameh M; Yahalom C; Blumenfeld A; Macarov M; Weisschuh N; Kohl S; Banin E; Sharon D
Mol Vis; 2021; 27():588-600. PubMed ID: 34703197
[TBL] [Abstract][Full Text] [Related]
6. Rod Monochromatism (Achromatopsia).
Tsang SH; Sharma T
Adv Exp Med Biol; 2018; 1085():119-123. PubMed ID: 30578497
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and Treatment Options for Achromatopsia: A Review of the Literature.
Pascual-Camps I; Barranco-Gonzalez H; Aviñó-Martínez J; Silva E; Harto-Castaño M
J Pediatr Ophthalmol Strabismus; 2018 Mar; 55(2):85-92. PubMed ID: 29257187
[TBL] [Abstract][Full Text] [Related]
8. Oligocone trichromacy: clinical and molecular genetic investigations.
Andersen MK; Christoffersen NL; Sander B; Edmund C; Larsen M; Grau T; Wissinger B; Kohl S; Rosenberg T
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):89-95. PubMed ID: 19797231
[TBL] [Abstract][Full Text] [Related]
9. Cortical Visual Mapping following Ocular Gene Augmentation Therapy for Achromatopsia.
McKyton A; Averbukh E; Marks Ohana D; Levin N; Banin E
J Neurosci; 2021 Sep; 41(35):7363-7371. PubMed ID: 34349002
[TBL] [Abstract][Full Text] [Related]
10. Safety and Vision Outcomes of Subretinal Gene Therapy Targeting Cone Photoreceptors in Achromatopsia: A Nonrandomized Controlled Trial.
Fischer MD; Michalakis S; Wilhelm B; Zobor D; Muehlfriedel R; Kohl S; Weisschuh N; Ochakovski GA; Klein R; Schoen C; Sothilingam V; Garcia-Garrido M; Kuehlewein L; Kahle N; Werner A; Dauletbekov D; Paquet-Durand F; Tsang S; Martus P; Peters T; Seeliger M; Bartz-Schmidt KU; Ueffing M; Zrenner E; Biel M; Wissinger B
JAMA Ophthalmol; 2020 Jun; 138(6):643-651. PubMed ID: 32352493
[TBL] [Abstract][Full Text] [Related]
11. Achromatopsia: Genetics and Gene Therapy.
Michalakis S; Gerhardt M; Rudolph G; Priglinger S; Priglinger C
Mol Diagn Ther; 2022 Jan; 26(1):51-59. PubMed ID: 34860352
[TBL] [Abstract][Full Text] [Related]
12. Progressive cone dystrophy associated with mutation in CNGB3.
Michaelides M; Aligianis IA; Ainsworth JR; Good P; Mollon JD; Maher ER; Moore AT; Hunt DM
Invest Ophthalmol Vis Sci; 2004 Jun; 45(6):1975-82. PubMed ID: 15161866
[TBL] [Abstract][Full Text] [Related]
13. Genetics and Disease Expression in the CNGA3 Form of Achromatopsia: Steps on the Path to Gene Therapy.
Zelinger L; Cideciyan AV; Kohl S; Schwartz SB; Rosenmann A; Eli D; Sumaroka A; Roman AJ; Luo X; Brown C; Rosin B; Blumenfeld A; Wissinger B; Jacobson SG; Banin E; Sharon D
Ophthalmology; 2015 May; 122(5):997-1007. PubMed ID: 25616768
[TBL] [Abstract][Full Text] [Related]
14. Molecular and Clinical Characterization of
Amaral RAS; Motta FL; Zin OA; da Palma MM; Rodrigues GD; Sallum JMF
Genes (Basel); 2023 Jun; 14(6):. PubMed ID: 37372476
[TBL] [Abstract][Full Text] [Related]
15. CNGB3 achromatopsia with progressive loss of residual cone function and impaired rod-mediated function.
Khan NW; Wissinger B; Kohl S; Sieving PA
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3864-71. PubMed ID: 17652762
[TBL] [Abstract][Full Text] [Related]
16. CNGB3 mutations account for 50% of all cases with autosomal recessive achromatopsia.
Kohl S; Varsanyi B; Antunes GA; Baumann B; Hoyng CB; Jägle H; Rosenberg T; Kellner U; Lorenz B; Salati R; Jurklies B; Farkas A; Andreasson S; Weleber RG; Jacobson SG; Rudolph G; Castellan C; Dollfus H; Legius E; Anastasi M; Bitoun P; Lev D; Sieving PA; Munier FL; Zrenner E; Sharpe LT; Cremers FP; Wissinger B
Eur J Hum Genet; 2005 Mar; 13(3):302-8. PubMed ID: 15657609
[TBL] [Abstract][Full Text] [Related]
17. Clinical heterogeneity between two Japanese siblings with congenital achromatopsia.
Hayashi T; Kozaki K; Kitahara K; Kubo A; Nishio Y; Omoto S; Nakamura Y; Watanabe A; Toda K; Ueoka Y
Vis Neurosci; 2004; 21(3):413-20. PubMed ID: 15518223
[TBL] [Abstract][Full Text] [Related]
18. Residual Foveal Cone Structure in CNGB3-Associated Achromatopsia.
Langlo CS; Patterson EJ; Higgins BP; Summerfelt P; Razeen MM; Erker LR; Parker M; Collison FT; Fishman GA; Kay CN; Zhang J; Weleber RG; Yang P; Wilson DJ; Pennesi ME; Lam BL; Chiang J; Chulay JD; Dubra A; Hauswirth WW; Carroll J;
Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):3984-95. PubMed ID: 27479814
[TBL] [Abstract][Full Text] [Related]
19. Disease Progression in
Tekavčič Pompe M; Vrabič N; Volk M; Meglič A; Jarc-Vidmar M; Peterlin B; Hawlina M; Fakin A
Curr Issues Mol Biol; 2021 Aug; 43(2):941-957. PubMed ID: 34449556
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
